Skip to main content

Table 2 Relative risks and 95% confidence intervals of myocardial infarction in each trial

From: The influence of gender on the effects of aspirin in preventing myocardial infarction

Source Male (%) Non–fatal MI Fatal MI Fatal and non-fatal MI
WHS [26] (2005) 0 1.02 (0.83–1.25) 1.17 (0.54–2.52) 1.03 (0.84–1.25)
PPP [19] (2001) 42 0.69 (0.36–1.34) 0.68 (0.19–2.40) 0.69 (0.39–1.23)
ACBS [18] (1995) 45 1.71 (0.51–5.75) NA NA
ETDRS [13] (1992) 52 NA NA 0.85(0.73–1.00)
SAPAT [24] (1992) 52 0.61 (0.43–0.87) 1.02 (0.50–2.07) 0.68 (0.50–0.92)
HOT [23] (1998) 53 NA NA 0.85 (0.69–1.05)
Swedish cooperative [8] (1987) 62 0.88 (0.45–1.72) 1.00 (0.33– 3.05) 0.91 (0.52, 1.60)
EAFT [14] (1993) 63 0.94 (0.35–2.47) 0.90 (0.52–1.56) 0.91 (0.56–1.46)
SALT [11] (1991) 66 0.91 (0.59–1.41) 0.65 (0.36–1.16) 0.80 (0.57–1.13)
Canadian group study [17] (1985) 70 1.29 (0.49–3.36) 0.54 (0.22–1.31) 0.80 (0.43–1.48)
SPAF [12] (1991) 71 0.57 (0.19–1.70) NA NA
Danish cooperative [27] (1983) 73 0.25 (0.05–1.16) 0.67 (0.20–2.31) 0.43 (0.17–1.08)
UK–TIA [22] (1991) 73 0.86 (0.68–1.11) 1.01 (0.74–1.39) 0.92 (0.77–1.11)
PARIS [5] (1980) 77 0.68 (0.47–1.01) 0.79 (0.55–1.15) 0.74 (0.57–0.95)
GAAT [16] (1980) 78 0.63 (0.39–1.03) 0.58 (0.30–1.12) 0.61 (0.42–0.89)
Cardiff–II [21] (1979) 85 0.49 (0.33–0.75) NA NA
AMIS [6] (1980) 89 0.78 (0.63–0.96) 1.08 (0.89–1.31) 0.93 (0.81–1.07)
Cardiff–I [20] (1974) 100 0.68 (0.31–1.49) NA NA
CDPA [7] (1980) 100 0.86 (0.52–1.42) NA NA
VACS [25] (1983) 100 0.49 (0.29–0.81) 0.17 (0.02–1.42) 0.45 (0.28–0.74)
PHS [9] (1989) 100 0.61 (0.49–0.75) 0.38 (0.19–0.80) 0.58 (0.47–0.72)
RISC [10] (1990) 100 0.49 (0.33–0.73) NA NA
TPT [15] (1998) 100 0.68 (0.53–0.89) 1.13 (0.78–1.63) 0.81 (0.66–0.99)
Total 49 0.72 (0.64–0.81) 0.88 (0.75–1.03) 0.79 (0.72–0.87)
  1. MI, myocardial infarction; NA, not available.
\